Patient Preparation Flashcards

1
Q

government oversite requires a preanesthesia evaluation by a qualified practitioner be completed within ____ of surgery

A

48 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why do we pre-op a patient?

A
  • optimize patient care and satisfaction
  • minimize perioperative morbidity and mortality
  • minimize surgical delays
  • determine postoperative disposition
  • evaluate patient’s health
  • formulate perianesthetic care plan
  • communicate patient issues among providers
  • educate patient to the perioperative process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 types of risks?

A
  • procedural
  • patient
  • anesthesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

procedural risk stratification

A
  • low (<1%) = cataract, ambulatory, endoscopic
  • intermediate (1-5%) = orthopedic, head and neck
  • high (>5%) = major vascular surgery

**AHA now divides into low (<1%) and elevated (>1%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

EF of ___ is an ______

A

<30%

independent risk factor for MACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 types of perioperative myocardial injury

A
  • transient cardiac contractile dysfunction (‘myocardial stunning’)
  • acute MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ischemia of ____ is associated with functional recovery

A

<20 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cardiac biomarkers

A
  1. myoglobin (start 2h, peak 4h)
  2. troponin (start 4h, peak 24h)
  3. total CK (peak 16h)
  4. CK-MB (peak 24)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

______ is the most obvious feature of MI and can occur within ____ of ischemia

A

contractile dysfunction

10-15 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database

A

-operation specific risk analysis: CABG, valve, CABG + valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

EuroScore II

A

-not validates with combined CABG + valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

consistent cardiac surgery risk factors

A

-age > 60
-female
-LV function < 30%
body habitus
-reoperation
-type of surgery
-urgency of surgery
-CKD
-DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

algorithm for non-cardiac surgery

A
  1. is the surgery emergent
  2. identify unstable cardiac conditions
  3. estimate perioperative risk
  4. low risk = proceed to surgery
  5. high risk = assess METS status (>4 =proceed to surgery)
  6. will further cardiac testing affect the plan (no = proceed
  7. yes = proceed to testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

METS

A

basal metabolic rate

3.5 mL/O2/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

criticism of revised cardiac risk index (RCRI)

A
  • 6 factors

- not surgery specific: underestimates vascular surgical risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

levels/class of evidence

A

level:
1 = multiple RCT
2 = single RCT, non-randomized
3 = expert opinion, case studies

class:
1 = should be
2a = reasonable
2b = considered
3 = harmful, not
17
Q

DES - timeline

A

-elective surgery at least 6 months, prefer 1 year

18
Q

bare metal stents - timeline

A
  • elective surgery at least 6 weeks

- 12 weeks if ACS

19
Q

a patient having an acute coronary syndrome should wait ____ before elective noncardiac surgery

A

60 days

20
Q

physiologic response after angioplasty

A
  1. arterial wall recoil
  2. arterial remodeling - wall contracts and lumen narrows
  3. neointimal hyperplasia
21
Q

in-stent restenosis peaks at ______, stent thrombosis peaks at _____

A

4-12 months

within first 30 days

22
Q

wall classifications during echo

A
  1. normal
  2. hypokinetic
  3. akinetic
  4. dyskinetic/aneurysmal (opposite movement)
23
Q

mitral/aortic regurgitation: mild/moderate/severe

A

mild <30%
moderate 30-50%
severe >50%

24
Q

mitral/aortic stenosis: mild/moderate/severe

A

mild >1.5
moderate 1-1.5
severe <1

25
Q

myocardial nuclear scintigraphy

A

more sensitive than stress test

26
Q

cardiac computed tomography

A

only valid in patients with no known CAD

27
Q

cardiac magnetic resonance imaging

A
myocardial scarring
aneurysm evaluation 
EF
heart mass
RV evaluation
28
Q

conduction pathway

A
  • SA node
  • IN pathways
  • AV node
  • IV conduction (LBB, RBB, purkinje fibers)